Trials / Completed
CompletedNCT00689377
Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention
Prevalence of Peripheral Arterial Disease in Subjects With a Moderate CVD Risk, With No Overt Vascular Diseases nOR diAbetes Mellitus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9,000 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
Non interventional study aimed to establish the prevalence of lower extremity peripheral arterial disease (PAD), defined as an ankle-brachial index (ABI) not above 0.90 in subjects with a moderate risk of cardiovascular disease, with no overt cardiovascular diseases nor diabetes mellitus.
Conditions
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2008-06-03
- Last updated
- 2012-03-20
Locations
331 sites across 6 countries: Belgium, France, Greece, Italy, Netherlands, Switzerland
Source: ClinicalTrials.gov record NCT00689377. Inclusion in this directory is not an endorsement.